Literature DB >> 4031075

Metabolic effect of 3,3',5'-triiodothyronine in cultured growth hormone-producing rat pituitary tumor cells. Evidence for a unique mechanism of thyroid hormone action.

D L St Germain.   

Abstract

Physiologic levels of 3,3',5'-triiodothyronine (rT3) are generally believed to have minimal metabolic effects in the pituitary gland and other tissues. In the present studies, the regulatory role of rT3 and other thyroid hormones on iodothyronine 5'-deiodinase (I5'D) activity was studied in a growth hormone-producing rat pituitary tumor cell line (GH3 cells). I5'D activity was thiol-dependent and displayed nonlinear reaction kinetics suggesting the presence of two enzymatic processes, one having a low Michaelis constant (Km for thyroxine [T4] of 2 nM) and a second with a high Km value (0.9 microM). Growth of cells in hormone-depleted medium resulted in a two- to 3.5-fold increase in low Km I5'D activity (P less than 0.001). The addition of thyroid hormones to the culture medium resulted in a rapid, dose-dependent inhibition of low Km I5'D activity with the following order of analogue potency: rT3 greater than or equal to T4 greater than 3,5,3'-triiodothyronine (T3). Using serum-free culture conditions, rT3 was approximately 50 times more active than T3. These inhibitory effects were noted within 15 min of hormone addition and could not be attributed to substrate competition with T4. These findings suggest that the control of T4 to T3 conversion by thyroid hormones in the anterior pituitary gland is mediated by a unique cellular mechanism that is independent of the nuclear T3 receptor; and under some circumstances, rT3 may play a regulatory role in controlling this enzymatic process.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4031075      PMCID: PMC423928          DOI: 10.1172/JCI112049

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Thyroid hormone action in pituitary cells. Differences in the regulation of thyrotropin-releasing hormone receptors and growth hormone synthesis.

Authors:  P M Hinkle; M H Perrone; T L Greer
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

Review 2.  Thyroid hormone action at the cellular level.

Authors:  J H Oppenheimer
Journal:  Science       Date:  1979-03-09       Impact factor: 47.728

3.  Clonal strains of hormone-producing pituitary cells.

Authors:  A H Tashjian
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

5.  Depletion of L-3,5,3'-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone.

Authors:  H H Samuels; F Stanley; J Casanova
Journal:  Endocrinology       Date:  1979-07       Impact factor: 4.736

6.  A study of extrathyroidal conversion of thyroxine (T4) to 3,3',5-triiodothyronine (T3) in vitro.

Authors:  I J Chopra
Journal:  Endocrinology       Date:  1977-08       Impact factor: 4.736

7.  Relationship of receptor affinity to the modulation of thyroid hormone nuclear receptor levels and growth hormone synthesis by L-triiodothyronine and iodothyronine analogues in cultured GH1 cells.

Authors:  H H Samuels; F Stanley; J Casanova
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

8.  The failure of physiologic doses of reverse T3 to effect thyroid-pituitary function in man.

Authors:  P Nicod; A Burger; G Strauch; A G Vagenakis; L E Braverman
Journal:  J Clin Endocrinol Metab       Date:  1976-08       Impact factor: 5.958

9.  Thyroid hormonelike actions of 3,3',5'-L-triiodothyronine nad 3,3'-diiodothyronine.

Authors:  S S Papavasiliou; J A Martial; K R Latham; J D Baxter
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

10.  Direct immunoassay of triiodothyronine in human serum.

Authors:  P R Larsen
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

View more
  3 in total

1.  Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues.

Authors:  W Croteau; J C Davey; V A Galton; D L St Germain
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 2.  Transcriptional regulation of mammalian selenoprotein expression.

Authors:  Zoia R Stoytcheva; Marla J Berry
Journal:  Biochim Biophys Acta       Date:  2009-05-22

3.  Restoration of type 1 iodothyronine deiodinase expression in renal cancer cells downregulates oncoproteins and affects key metabolic pathways as well as anti-oxidative system.

Authors:  Piotr Popławski; Jacek R Wiśniewski; Eddy Rijntjes; Keith Richards; Beata Rybicka; Josef Köhrle; Agnieszka Piekiełko-Witkowska
Journal:  PLoS One       Date:  2017-12-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.